Simplex Trading, LLC Neurocrine Biosciences Inc Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$130.86 - $143.19 $1.26 Million - $1.38 Million	9,648 New	9,648 $1.33 Million
Q3 2022 Nov 04, 2022	SELL	$92.03 - $107.81 $992,543 - $1.16 Million	-10,785 Reduced 76.47%	3,318 $352,000
Q2 2022 Aug 03, 2022	SELL	$75.79 - $100.07 $716,670 - $946,261	-9,456 Reduced 40.14%	14,103 $1.37 Million
Q1 2022 May 02, 2022	BUY	$72.45 - $94.81 $1.31 Million - $1.72 Million	18,150 Added 335.55%	23,559 $2.21 Million
Q3 2021 Oct 28, 2021	SELL	$86.18 - $99.03 $68,944 - $79,224	-800 Reduced 12.88%	5,409 $527,000
Q2 2021 Aug 12, 2021	BUY	$89.43 - $102.27 $555,270 - $634,994	6,209 New	6,209 $604,000
Q1 2021 Apr 26, 2021	SELL	$87.57 - $119.4 $101,756 - $138,742	-1,162 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$86.91 - $108.33 $480,525 - $598,956	-5,529 Reduced 82.63%	1,162 $111,000
Q3 2020 Oct 14, 2020	BUY	$96.16 - $135.15 $643,310 - $904,153	6,690 Added 669000.0%	6,691 $643,000
Q2 2020 Jul 13, 2020	BUY	$85.09 - $130.36 $85 - $130	1 New	1 $0
Q4 2019 Feb 05, 2020	SELL	$86.8 - $118.57 $1.17 Million - $1.6 Million	-13,502 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$83.82 - $101.5 $433,852 - $525,364	5,176 Added 62.17%	13,502 $1.22 Million
Q2 2019 Jul 26, 2019	BUY	$72.24 - $91.27 $79,680 - $100,670	1,103 Added 15.27%	8,326 $702,000
Q1 2019 Apr 18, 2019	BUY	$69.31 - $91.53 $500,626 - $661,121	7,223 New	7,223 $0
Q4 2018 Jan 16, 2019	SELL	$68.32 - $124.36 $468,196 - $852,239	-6,853 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$98.88 - $125.85 $219,118 - $278,883	-2,216 Reduced 24.43%	6,853 $842,000
Q2 2018 Jul 30, 2018	BUY	$75.3 - $105.99 $667,835 - $940,025	8,869 Added 4434.5%	9,069 $890,000
Q1 2018 Apr 26, 2018	BUY	$75.88 - $92.43 $15,176 - $18,486	200 New	200 $16,000
Q4 2017 Jan 10, 2018	SELL	$58.53 - $77.59 $62,978 - $83,486	-1,076 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$47.97 - $61.28 $51,615 - $65,937	1,076	1,076 $65,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.77 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.25 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$644 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$322 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$233 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account